Tag: Donanemab
Second Alzheimer’s Drug in the Pipeline Promises to Slow Worsening but...
WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
Eli Lilly...